Literature DB >> 18314436

Spinal cord compression in patients with advanced metastatic cancer: "all I care about is walking and living my life".

Janet L Abrahm1, Michael B Banffy, Mitchel B Harris.   

Abstract

As 1 of the 12,700 US cancer patients who, each year, develops metastatic spinal cord compression, Ms H wishes to walk and live her life. Sadly, this wish may be difficult to fulfill. Before diagnosis, 83% to 95% of patients experience back pain, which often is referred, obscuring the site(s) of the compression(s). Prediction of ambulation depends on a patient's ambulatory status before therapy and time between developing motor defects and starting therapy. Ambulatory patients with no visceral metastases and more than 15 days between developing motor symptoms and receiving therapy have the best rate of survival. To preserve ambulation and optimize survival, magnetic resonance imaging should be performed for cancer patients with new back pain despite normal neurological findings. At diagnosis, counseling, pain management, and corticosteroids are begun. Most patients are offered radiation therapy. Surgery followed by radiation is considered for selected patients with a single high-grade epidural lesion caused by a radioresistant tumor who also have an estimated survival of more than 3 months. Team discussions with the patient and support network help determine therapy options and include patient goals; assessment of risks, benefits, and burdens of each treatment; and discussion of the odds of preserving prognosis of ambulation and of the effect of therapy on the patient's overall prognosis. Rehabilitation improves impaired function and its associated depression. Clinicians can help patients cope with transitions in self-image, independence, family and community roles, and living arrangements and can help patients with limited prognoses identify their end-of-life goals and preferences about resuscitation and entering hospice.

Entities:  

Mesh:

Year:  2008        PMID: 18314436     DOI: 10.1001/jama.299.8.937

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

Review 1.  Rehabilitation and treatment of spinal cord tumors.

Authors:  Vishwa S Raj; Latanya Lofton
Journal:  J Spinal Cord Med       Date:  2013-01       Impact factor: 1.985

2.  Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumours.

Authors:  Leonid Gibiansky; Liviawati Sutjandra; Sameer Doshi; Jenny Zheng; Winnie Sohn; Mark C Peterson; Graham R Jang; Andrew T Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

Review 3.  Clinical efficacy of denosumab versus bisphosphonates for the prevention of bone complications: implications for nursing.

Authors:  Cynthia Campbell-Baird; Stacey Harrelson; Georgette Frey; Arun Balakumaran
Journal:  Support Care Cancer       Date:  2015-08-23       Impact factor: 3.603

4.  Non-pharmacological interventions in patients with spinal cord compression: a systematic review.

Authors:  María Paniagua-Collado; Omar Cauli
Journal:  J Neurooncol       Date:  2017-11-20       Impact factor: 4.130

5.  Effectiveness of radiotherapy for metastatic spinal cord compression in patients with short life expectancy.

Authors:  Alexandra Giraldo; Sergi Benavente; Mónica Ramos; Ramona Vergés; Odimar Coronil; Lina Arbeláez; Xavier Maldonado; Manuel Altabas; Meritxell Mollà; Victoria Reyes; Begoña Navalpotro; Jordi Giralt
Journal:  Rep Pract Oncol Radiother       Date:  2016-11-05

Review 6.  Diagnosis and surgical management of breast cancer metastatic to the spine.

Authors:  Derek G Ju; Alp Yurter; Ziya L Gokaslan; Daniel M Sciubba
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  Preoperative prediction for regaining ambulatory ability in paretic non-ambulatory patients with metastatic spinal cord compression.

Authors:  M Ohashi; T Hirano; K Watanabe; K Katsumi; H Shoji; A Sano; H Tashi; I Takahashi; M Wakasugi; Y Shibuya; N Endo
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

8.  Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.

Authors:  Alysia N Lozano-Ondoua; Katherine E Hanlon; Ashley M Symons-Liguori; Tally M Largent-Milnes; Josh J Havelin; Henry L Ferland; Anupama Chandramouli; Mabel Owusu-Ankomah; Tijana Nikolich-Zugich; Aaron P Bloom; Juan Miguel Jimenez-Andrade; Tamara King; Frank Porreca; Mark A Nelson; Patrick W Mantyh; Todd W Vanderah
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

9.  Metastatic non-Hodgkin lymphoma presenting as low back pain and radiculopathy: a case report.

Authors:  Inger K Roug; Larry B McCartney
Journal:  J Chiropr Med       Date:  2012-09

10.  Suspected malignant cord compression - improving time to diagnosis via a 'hotline': a prospective audit.

Authors:  L Allan; L Baker; J Dewar; S Eljamel; R M Grant; J G Houston; T McLeay; A J Munro; P Levack
Journal:  Br J Cancer       Date:  2009-05-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.